5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.40▼ | 3.40▼ | 3.42▼ | 3.44▼ | 3.45▼ |
MA10 | 3.40▼ | 3.41▼ | 3.45▼ | 3.41▼ | 3.45▼ |
MA20 | 3.41▼ | 3.45▼ | 3.49▼ | 3.51▼ | 3.22▲ |
MA50 | 3.41▼ | 3.46▼ | 3.41▼ | 3.48▼ | 4.21▼ |
MA100 | 3.45▼ | 3.39▼ | 3.45▼ | 3.17▲ | 6.17▼ |
MA200 | 3.49▼ | 3.47▼ | 3.57▼ | 3.78▼ | 12.92▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.007▼ | -0.019▼ | -0.011▼ | 0.114▲ |
RSI | 40.474▼ | 39.904▼ | 42.178▼ | 46.909▼ | 47.200▼ |
STOCH | 30.417 | 29.000 | 17.821▼ | 59.163 | 51.553 |
WILL %R | -90.000▼ | -93.103▼ | -96.296▼ | -47.552 | -46.721 |
CCI | -93.633 | -81.429 | -92.338 | -11.908 | 33.464 |
Sunday, August 17, 2025 08:55 PM
Relay Therapeutics Inc. (NASDAQ:RLAY) is one of the most promising penny stocks under $5. On August 8, Raymond James lowered the firm’s price target on Relay Therapeutics to $19 from $29, while ...
|
Tuesday, August 12, 2025 08:28 PM
Detailed price information for Relay Therapeutics Inc (RLAY-Q) from The Globe and Mail including charting and trades.
|
Thursday, August 07, 2025 05:09 PM
Relay Therapeutics beat analyst estimates for both GAAP revenue and earnings per share in Q2 2025. The company reported continued clinical advancement of its lead asset RLY-2608, with new positive ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/08/25 | 3.48 | 3.52 | 3.375 | 3.40 | 1,343,226 |
18/08/25 | 3.54 | 3.65 | 3.465 | 3.47 | 895,144 |
15/08/25 | 3.43 | 3.56 | 3.40 | 3.54 | 1,409,357 |
14/08/25 | 3.36 | 3.405 | 3.31 | 3.39 | 1,458,967 |
13/08/25 | 3.44 | 3.61 | 3.40 | 3.42 | 1,591,594 |
12/08/25 | 3.27 | 3.375 | 3.24 | 3.35 | 1,788,585 |
11/08/25 | 3.21 | 3.36 | 3.15 | 3.25 | 2,367,974 |
08/08/25 | 3.18 | 3.39 | 3.025 | 3.22 | 4,399,770 |
07/08/25 | 3.58 | 3.58 | 3.405 | 3.49 | 1,599,200 |
06/08/25 | 3.53 | 3.565 | 3.455 | 3.53 | 1,369,707 |
|
|
||||
|
|
||||
|
|